UroGen Pharma
URGN
#6896
Rank
โ‚ฌ0.40 B
Marketcap
8,68ย โ‚ฌ
Share price
-2.37%
Change (1 day)
-32.60%
Change (1 year)

EPS for UroGen Pharma (URGN)

EPS in 2023 (TTM): -4,43ย โ‚ฌ

According to UroGen Pharma's latest financial reports the company's current EPS (TTM) is -4,12ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,20ย โ‚ฌ an increase over its 2021 EPS that were of -4,36ย โ‚ฌ.

EPS history for UroGen Pharma from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,43ย โ‚ฌ5.29%
2022-4,20ย โ‚ฌ-3.63%
2021-4,36ย โ‚ฌ-16.22%
2020-5,21ย โ‚ฌ15.63%
2019-4,50ย โ‚ฌ7.56%
2018-4,19ย โ‚ฌ160.58%
2017-1,61ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ-53.42%๐Ÿ‡บ๐Ÿ‡ธ USA